Table 2.
Groups | Markers | Model | L-Icariin | M-Icariin | H-Icariin |
---|---|---|---|---|---|
Young | OC (ng/mL) | 1.78 ± 0.065 | 1.79 ± 0.067 | 1.83 ± 0.057 | 2.27 ± 0.064*,# |
BAP (U/mg prot) | 36.3 ± 1.57 | 41.05 ± 1.81 | 48.86 ± 1.10* | 60.85 ± 2.03*,# | |
NTX-1 (ng/mL) | 1.05 ± 0.057 | 1.15 ± 0.062 | 1.21 ± 0.062* | 1.59 ± 0.071*,# | |
CTX-1 (ng/mL) | 0.50 ± 0.041 | 0.55 ± 0.048 | 0.67 ± 0.052* | 1.18 ± 0.067*,# | |
Old | OC (ng/mL) | 0.94 ± 0.058 | 1.42 ± 0.061* | 1.51 ± 0.063* | 1.86 ± 0.064*,# |
BAP (U/mg prot) | 22.45 ± 1.64 | 25.34 ± 2.15 | 32.69 ± 1.50* | 49.65 ± 2.41*,# | |
NTX-1 (ng/mL) | 0.71 ± 0.052 | 0.85 ± 0.049 | 0.95 ± 0.058* | 1.20 ± 0.063*,# | |
CTX-1 (ng/mL) | 0.28 ± 0.058 | 0.41 ± 0.053* | 0.51 ± 0.055* | 0.96 ± 0.053*,# |
Data are represented as the means ± SD (n = 3).
p< 0.05 vs. model group.
p< 0.05 vs. L-Icariin group.